H.R. 413 (113th Congress): To eliminate the 2-year delay in including oral-only ESRD-related drugs in the Medicare ESRD prospective payment system, as provided under section 632(b)(1) of the American Taxpayer Relief Act of 2012.
H.R. 413 in the 113th Congress is titled "To eliminate the 2-year delay in including oral-only ESRD-related drugs in the Medicare ESRD prospective payment system, as provided under section 632(b)(1) of the American Taxpayer Relief Act of 2012.." The latest action in the official record, dated February 8, 2013, reads: "Referred to the Subcommittee on Health."
- Latest official action
- Official source
- Congress.gov ↗
- Last checked
Cite this record
- Reference number
bill-113-hr413- Permanent link
- https://powerandpolitics.co/cite/bill-113-hr413
- Official source
- Congress.gov ↗
- Last checked
- Status and actions last read from the official GovInfo BILLSTATUS record
Power & Politics, "H.R. 413 (113th Congress): To eliminate the 2-year delay in including oral-only ESRD-related drugs in the Medicare ESRD prospective payment system, as provided under section 632(b)(1) of the American Taxpayer Relief Act of 2012," last checked Oct. 12, 2026, citing Congress.gov, https://powerandpolitics.co/cite/bill-113-hr413
Power & Politics. (2026, October 12). H.R. 413 (113th Congress): To eliminate the 2-year delay in including oral-only ESRD-related drugs in the Medicare ESRD prospective payment system, as provided under section 632(b)(1) of the American Taxpayer Relief Act of 2012 [Bill record]. Retrieved October 28, 2026, from https://powerandpolitics.co/cite/bill-113-hr413
Power & Politics. "H.R. 413 (113th Congress): To eliminate the 2-year delay in including oral-only ESRD-related drugs in the Medicare ESRD prospective payment system, as provided under section 632(b)(1) of the American Taxpayer Relief Act of 2012." Last modified October 12, 2026. Accessed October 28, 2026. https://powerandpolitics.co/cite/bill-113-hr413.
@misc{votefiles_bill_113_hr413,
author = {{Power & Politics}},
title = {{H.R. 413 (113th Congress): To eliminate the 2-year delay in including oral-only ESRD-related drugs in the Medicare ESRD prospective payment system, as provided under section 632(b)(1) of the American Taxpayer Relief Act of 2012}},
year = {2026},
howpublished = {\url{https://powerandpolitics.co/cite/bill-113-hr413}},
note = {Reference number bill-113-hr413; official source: Congress.gov, https://www.congress.gov/bill/113th-congress/house-bill/413; last checked October 12, 2026; accessed October 28, 2026}
}https://powerandpolitics.co/cite/bill-113-hr413
Cite the official source for the underlying fact. Power & Politics reference number never changes for this record. AP, APA and Chicago are standard citation styles for news and academic writing, and BibTeX is the format reference-manager programs read.
This reference number is built from the record's official identifier and never changes. The official source is the authority for the underlying fact; Power & Politics links it so any reader can check it. The same record is available as a data download, and complete collections of records are on the open data page.